Knockdown of microRNA-181a inhibits osteosarcoma cells growth and invasion through triggering NLRP3-dependent

B-G Tian1, Z Hua, Z-J Wang

  • 1Department of Orthopedics, Wuxi traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine, Wuxi, Jiangsu, China. zhiyan021939264@163.com.

Abstract

Insights

MicroRNA-181a (miRNA-181a) is elevated in osteosarcoma, promoting cancer progression. Inhibiting miRNA-181a activates pyroptosis, offering a potential therapeutic strategy for osteosarcoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Osteosarcoma is a primary bone malignancy with limited effective treatments.
  • MicroRNAs play crucial roles in cancer development and progression.
  • The specific role of microRNA-181a (miRNA-181a) in osteosarcoma pathogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the physiological function of miRNA-181a in osteosarcoma.
  • To elucidate the molecular mechanisms underlying miRNA-181a's role in osteosarcoma carcinogenesis.
  • To evaluate miRNA-181a as a potential therapeutic target for osteosarcoma.

Main Methods:

  • Quantitative real-time polymerase chain reaction (qRT-PCR) to measure miRNA-181a expression.
  • In vitro assays (Cell Counting Kit-8, transwell, Western blotting, TUNEL) to assess cell proliferation, invasion, apoptosis, and protein levels.
  • In vivo studies using a xenograft tumor model in mice to evaluate therapeutic effects.
  • Manipulation of miRNA-181a levels using inhibitors and mimics.

Main Results:

  • miRNA-181a was significantly upregulated in osteosarcoma tissues and cells.
  • Overexpression of miRNA-181a promoted cell proliferation and migration, while knockdown inhibited these processes.
  • Downregulation of miRNA-181a induced NOD-like receptor protein 3 (NLRP3)-dependent pyroptosis, suppressing tumor growth in vitro and in vivo.
  • Silencing NLRP3 reversed the effects of miRNA-181a inhibition.

Conclusions:

  • miRNA-181a plays a pro-carcinogenic role in osteosarcoma by promoting proliferation and migration.
  • miRNA-181a functions by suppressing NLRP3-dependent pyroptosis.
  • Targeting miRNA-181a represents a promising therapeutic strategy for osteosarcoma treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K